---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-027511"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2024-08-21T23:59:59+00:00"
generated_at: "2026-05-31T08:16:58.657362+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Reviva prices $5.0M at-the-market offering of common stock and warrants

## Summary
- Offering comprises 4,761,905 shares (or pre-funded warrants) plus warrants for same number; combined price $1.05 per unit.
- Warrants exercisable at $0.7964/share, expire 5 years from issuance; pre-funded warrants at $0.0001/share.
- Existing warrants for up to 4,736,561 shares amended to $0.7964 exercise price and 5-year term for $0.125 per warrant.
- Net proceeds expected to fund Phase 3 RECOVER-2 trial and working capital; gross proceeds ~$5.0M.
- Titan Partners Group is sole bookrunner; closing expected August 22, 2024.

## SEC filing metadata
- accession: 0001437749-24-027511
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2024-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774924027511/0001437749-24-027511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924027511/rvph20240821_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-027511
- JSON: https://secwatch.observer/filing/0001437749-24-027511.json
- Plain text: https://secwatch.observer/filing/0001437749-24-027511.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.